L. Klumpers

发表

Novel approaches in clinical development of cannabinoid drugs

L. Klumpers, 2014 .

Population Pharmacokinetic Model of THC Integrates Oral, Intravenous, and Pulmonary Dosing and Characterizes Short- and Long-term Pharmacokinetics

P. Morrison, T. Beumer, J. Freijer, 2015, Clinical Pharmacokinetics.

A Brief Background on Cannabis: From Plant to Medical Indications.

L. Klumpers, D. L. Thacker, 2019, Journal of AOAC International.

Surinabant, a selective cannabinoid receptor type 1 antagonist, inhibits Δ9-tetrahydrocannabinol-induced central nervous system and heart rate effects in humans.

J. V. van Gerven, G. Ferron, L. Zuurman, 2013, British journal of clinical pharmacology.

Pharmacokinetic/pharmaco-dynamic modelling and simulation of the effects of different cannabinoid receptor type 1 antagonists on Δ(9)-tetrahydrocannabinol challenge tests.

J. V. van Gerven, J. Stevens, J. Heuberger, 2015, British journal of clinical pharmacology.

Pharmacokinetic / pharmacodynamic modelling and simulation of the effects of different cb ¡ antagonists on ∆ 9 -tetrahydrocannabinol challenge tests in healthy volunteers

Z. Guan, L. Klumpers, 2014 .

Comparative pharmacology with Δ-THC

M. Tagen, L. Klumpers, 2022 .

Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.

J. V. van Gerven, T. Beumer, M. D. de Kam, 2012, British journal of clinical pharmacology.

Review of delta‐8‐tetrahydrocannabinol (Δ8‐THC): Comparative pharmacology with Δ9‐THC

M. Tagen, L. Klumpers, 2022, British journal of pharmacology.

Manipulating brain connectivity with δ9-tetrahydrocannabinol: A pharmacological resting state FMRI study

David M. Cole, Serge A. R. B. Rombouts, Najmeh Khalili-Mahani, 2012, NeuroImage.

Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects.

J. V. van Gerven, C. Elling, M. D. de Kam, 2013, British journal of clinical pharmacology.

Brief Treatment With the Glucocorticoid Receptor Antagonist Mifepristone Normalises the Corticosterone‐Induced Reduction of Adult Hippocampal Neurogenesis

M. Joëls, P. Lucassen, E. D. de Kloet, 2006, Journal of neuroendocrinology.

Subjective Effects of Ethanol, Morphine, Δ9-Tetrahydrocannabinol, and Ketamine Following a Pharmacological Challenge Are Related to Functional Brain Connectivity

Najmeh Khalili-Mahani, Marieke Niesters, Albert Dahan, 2015, Brain Connect..

The risk of chronic psychedelic and MDMA microdosing for valvular heart disease

D. Mantuani, M. Tagen, R. Knowles, 2023, Journal of psychopharmacology.

The Therapeutic Potential of Cannabis and the Endocannabinoid System

A. Hazekamp, L. Klumpers, 2019, Principles and Practice of Botanicals as an Integrative Therapy.